<DOC>
	<DOCNO>NCT02178475</DOCNO>
	<brief_summary>Prospective observational study febrile neutropenia ( FN ) pegfilgrastim primary prophylaxis breast cancer non-Hodgkin 's lymphoma patient receive high ( &gt; 20 % ) FN-risk chemotherapy</brief_summary>
	<brief_title>Prospective Observational Study Febrile Neutropenia ( FN ) Pegfilgrastim Primary Prophylaxis Breast Cancer Non-Hodgkin 's Lymphoma Patients Receiving High ( &gt; 20 % ) FN-risk Chemotherapy</brief_title>
	<detailed_description>A prospective study design enable collection reason physician choose discontinue pegfilagrastim PP end chemotherapy course . Additionally , facilitate data collection sufficient quality magnitude reliably estimate neutropenic outcome , pegfilgrastim discontinuation rate , subject characteristic discontinue .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Chemotherapy-Induced Febrile Neutropenia</mesh_term>
	<criteria>Age â‰¥ 18 year old . Any stage NHL breast cancer receive first cycle new chemotherapy course . Received first cycle permit standard dose chemotherapy regimen estimate high ( &gt; 20 % ) FN risk accord publish data guideline ( dose modification +/10 % Cycle 1 allowable ) . Initiated treatment Cycle 1 pegfilgrastim accord pegfilgrastim SmPC . Enrolment must occur first pegfilgrastim dose Cycle 1 second day Cycle 2 . Ongoing planned concurrent participation clinical study involve Investigational Product approve national competent authority indication . Ongoing plan concurrent participation clinical study administration Colony Stimulating Factor ( CSF ) determine protocol ( clinical trial approve drug observational trial permit long mandate neutropenia treat ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>NHL</keyword>
	<keyword>Breast Cancer</keyword>
</DOC>